Vol 4: Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about DonorsReport as inadecuate



 Vol 4: Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors


Vol 4: Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors - Download this document for free, or read online. Document in PDF available to download.

Download or read this book online for free in PDF: Vol 4: Living Donor Liver Transplantation for Hepatocellular Carcinoma: It Is All about Donors
This article is from International Journal of Organ Transplantation Medicine, volume 4.AbstractBackground: Live-donor liver transplantation LDLT is a valuable option for patients with hepatocellular carcinoma HCC as compared with deceased-donor liver transplantation DDLT; the tumor could be eradicated early.Methods: Herein, we reviewed the outcome of adult patients with HCC who underwent LDLT from 1990 to 2009 in the USA, as reported to United Network for Organ Sharing. Results: Compared to DDLT n=5858, patients who underwent LDLT for HCC n=170 were more likely to be female 43.8% vs 23.8%, younger mean age 48.6 vs 54.9 years and have more tumors outside Milan criteria 30.7% vs 13.6%. However, the recipients of LDLT for HCC had a significantly shorter mean wait time before transplantation 173 vs 219 days; p=0.04. The overall allograft and patient survival were not different, though more patients in LDLT group were outside Milan criteria. Since implementation of the MELD exception for HCC, DDLT for HCC has increased form 337 2.3% cases in 2002 to 1142 18.7% in 2009 p



Author: Saidi, R. F.; Li, Y.; Shah, S. A.; Jabbour, N.

Source: https://archive.org/







Related documents